Cargando…

LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma

Tumor cells require high levels of cholesterol for membrane biogenesis for rapid proliferation during development. Beyond the acquired cholesterol from low-density lipoprotein (LDL) taken up from circulation, tumor cells can also biosynthesize cholesterol. The molecular mechanism underlying choleste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Mingyue, Luo, Jing, Gu, Tong, Yu, Xiaojuan, Song, Zhen, Jun, Yali, Gu, Hao, Han, Kairong, Huang, Xiujuan, Yu, Weiyong, Sun, Su’an, Zhang, Zhengwei, Liu, Lu, Chen, Xiaofei, Zhang, Li, Luo, Chao, Wang, Qilong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438019/ https://www.ncbi.nlm.nih.gov/pubmed/34518524 http://dx.doi.org/10.1038/s41419-021-04132-6

Ejemplares similares

Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

Self-assembled RNA nanocarrier-mediated chemotherapy combined with molecular targeting in the treatment of esophageal squamous cell carcinoma
por: Li, Xiang, et al.
Publicado: (2021)

Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer
por: Lv, Yanguan, et al.
Publicado: (2020)

LPCAT2 controls chemoresistance in colorectal cancer
por: Cotte, Alexia Karen, et al.
Publicado: (2018)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

ROBO4 deletion ameliorates PAF-mediated skin inflammation via regulating the mRNA translation efficiency of LPCAT1/LPCAT2 and the expression of PAF receptor
por: Xiao, Xiaoqiang, et al.
Publicado: (2020)

LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma
por: Zhang, Hongbin, et al.
Publicado: (2020)

Pan-cancer analysis identifies LPCATs family as a prognostic biomarker and validation of LPCAT4/WNT/β-catenin/c-JUN/ACSL3 in hepatocellular carcinoma
por: Lu, Yaoyong, et al.
Publicado: (2023)

LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway
por: Wei, Chunhua, et al.
Publicado: (2019)

LPCAT1 controls phosphate homeostasis in a zinc-dependent manner
por: Kisko, Mushtak, et al.
Publicado: (2018)

PTIP Inhibits Cell Invasion in Esophageal Squamous Cell Carcinoma via Modulation of EphA2 Expression
por: Han, Xiao, et al.
Publicado: (2021)

Coronaviral Main Protease Induces LPCAT3 Cleavage and Endoplasmic Reticulum (ER) Stress
por: Wang, Jia, et al.
Publicado: (2023)

LPCAT1 is transcriptionally regulated by FOXA1 to promote breast cancer progression and paclitaxel resistance
por: Zhang, Huayi, et al.
Publicado: (2023)

Phosphatidylcholine formation by LPCAT1 is regulated by Ca(2+) and the redox status of the cell
por: Soupene, Eric, et al.
Publicado: (2012)

Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer
por: Shao, Gaoxuan, et al.
Publicado: (2022)

LPCAT4 Knockdown Alters Barrier Integrity and Cellular Bioenergetics in Human Urothelium
por: Mason, Andrew S., et al.
Publicado: (2022)

Ferroptosis-related genes LPCAT3 and PGD are potential diagnostic biomarkers for osteoarthritis
por: Wang, Lufei, et al.
Publicado: (2023)

Lpcat3 deficiency promotes palmitic acid-induced 3T3-L1 mature adipocyte inflammation through enhanced ROS generation: Lpcat3 deficiency promotes adipocyte inflammation
por: Hu, Jiachun, et al.
Publicado: (2022)

miR-203 affects esophageal cancer cell proliferation, apoptosis and invasion by targeting MAP3K1
por: Zong, Mingzhu, et al.
Publicado: (2020)

Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion
por: Rong, Xin, et al.
Publicado: (2015)

LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
por: Li, Lan, et al.
Publicado: (2022)

Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating TGF-β/Smad2/3 signaling pathway: Tumor-promoting effect of LPCAT1 in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2022)

LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1
por: Ji, Weidan, et al.
Publicado: (2021)

Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer
por: Zhao, Tianyi, et al.
Publicado: (2021)

Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport
por: Hashidate-Yoshida, Tomomi, et al.
Publicado: (2015)

Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer
por: Lebok, Patrick, et al.
Publicado: (2019)

Mitochondrial Reactive Oxygen Species Formation Determines ACSL4/LPCAT2-Mediated Ferroptosis
por: Merkel, Melanie, et al.
Publicado: (2023)

Triacylglycerol synthesis by PDAT1 in the absence of DGAT1 activity is dependent on re-acylation of LPC by LPCAT2
por: Xu, Jingyu, et al.
Publicado: (2012)

LPCAT1-TERT fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth
por: Oliver, Gavin R., et al.
Publicado: (2021)

LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production
por: Han, Chao, et al.
Publicado: (2020)

CEP55 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma and Is Correlated with Poor Prognosis
por: Yan, Shu-Mei, et al.
Publicado: (2021)

Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice
por: Li, Minghuan, et al.
Publicado: (2016)

Plant Acyl-CoA:Lysophosphatidylcholine Acyltransferases (LPCATs) Have Different Specificities in Their Forward and Reverse Reactions
por: Lager, Ida, et al.
Publicado: (2013)

Liver-specific overexpression of LPCAT3 reduces postprandial hyperglycemia and improves lipoprotein metabolic profile in mice
por: Cash, J G, et al.
Publicado: (2016)

LPCAT1 enhances the invasion and migration in gastric cancer: Based on computational biology methods and in vitro experiments
por: Chen, Zu‐Xuan, et al.
Publicado: (2023)

Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma
por: Su, Zhijian, et al.
Publicado: (2022)

Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
por: Wang, Mingyue, et al.
Publicado: (2019)

Gut Microbiota Dysbiosis Accelerates Prostate Cancer Progression Through Increased LPCAT1 Expression and Enhanced DNA Repair Pathways
por: Liu, Yufei, et al.
Publicado: (2021)

Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma
por: Li, Minjuan, et al.
Publicado: (2020)

Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest
por: Ye, Liping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p7qlbbbomkhpgsrhjek92vauus